From New York it is about 11.5h to Sofia. A full programme at Stem Plus costs €3,000–€8,000 — versus €18,400–€46,000 at home — with European GMP standards.
US-based patients exploring stem-cell therapy face a fragmented regulatory landscape. FDA oversight limits domestic options to a handful of approved therapies and carefully monitored trials, while many regenerative clinics operate in grey zones or market unproven treatments. This creates a paradox: America leads in research but restricts patient access. Costs for unproven treatments at US clinics often run $15,000–50,000, sometimes for autologous procedures with limited clinical backing. Travel to Bulgaria offers American patients a different calculus: transparent GMP manufacturing, established EU regulatory standards, and costs typically 40–60% lower than comparable US clinic pricing. EU-trained Bulgarian specialists follow strict quality protocols absent in many US clinics, and patients benefit from documented manufacturing records and allogeneic cell lines audited by international bodies. Many American patients pursuing regenerative medicine already travel domestically; accessing Bulgaria's established cell-therapy infrastructure—with direct flights via major hubs—represents a disciplined, regulated alternative to riskier domestic options. Language and medical tourism logistics are routine for American patients; Bulgaria combines European standards with significant cost relief.
| the United States (דף הבית) | Stem Plus · EU | |
|---|---|---|
| Typical cost | €18,400–€46,000 | €3,000–€8,000 |
| Regulation | varies | EU · GMP |
| Flight to Sofia | 11.5h from New York | — |
Cost ranges are indicative market figures for planning, not quotes.
רפואה רגנרטיבית מאושרת GMP בלב האיחוד האירופי — החל מ-3,000–8,000 יורו, חלק קטן ממחירי ארהב או גרמניה. פרוטוקולים מותאמים אישית למטופלים מ-50+ מדינות.
בדיקה רפואית חינם